Helius Medical Technologies is trading 6.64% lower at $2.67 amid its announcement of pricing a $15 million registered direct offering. - The company announced the pricing at 1:57 p.m. ET on September 30. - The available release listing does not provide offering terms, and no source explicitly attributes the decline to the offering. - No current volume or activity data was available in the provided sources.